Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways


September 15, 2017
Jain, P., A. Silva, H. J. Han, S. S. Lang, Y. Zhu, K. Boucher, T. E. Smith, A. Vakil, P. Diviney, N. Choudhari, P. Raman, C. M. Busch, T. Delaney, X. Yang, A. K. Olow, S. Mueller, D. Haas-Kogan, E. Fox, P. B. Storm, A. C. Resnick, and A. J. Waanders